Carl Zeiss Meditec (AFX)


Carl Zeiss Meditec stock research in summary

tec.zeiss.com


Latest Obermatt Ranks

Country Germany
Industry Health Care Equipment
Index TecDAX
Size class Medium

December 15, 2017. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()


Achievements

Top 10 Stock






 

Research History: Carl Zeiss Meditec

STOCK RESEARCH SUMMARY 2014 2015 2016 2017
STOCK VALUE RANKS
58
58
38
35
STOCK GROWTH RANKS
58
78
64
77
STOCK SAFETY RANKS
1
1
93
21
COMBINED STOCK RANKS
11
11
86
48

Last update of Combined Rank:

Historic Carl Zeiss Meditec stock analysis based on the Obermatt Method. The higher the rank, the better is Carl Zeiss Meditec in the corresponding investment strategy.


Value Metrics in Detail

VALUE METRICS 2014 2015 2016 2017
PRICE VS. REVENUES (P/S)
25
87
28
PRICE VS. PROFITS (P/E)
48
48
41
PRICE VS. CAPITAL (Market-to-Book)
53
30
39
DIVIDEND YIELD
52
38
54
CONSOLIDATED RANK: VALUE
58
58
38
35

Last update of Value Rank:

Carl Zeiss Meditec stock analysis in respect to important value ratios. The higher the rank, the lower the value ratio; except for dividend yield where the rank is higher the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2014 2015 2016 2017
REVENUE GROWTH
70
55
16
PROFIT GROWTH
63
77
67
STOCK RETURNS
27
71
78
CONSOLIDATED RANK: GROWTH
58
78
64
77

Financial reporting date of Growth Rank:

Carl Zeiss Meditec stock analysis in respect to important growth metrics. The higher the rank, the higher the growth and returns.


Safety Metrics in Detail

SAFETY METRICS 2014 2015 2016 2017
LEVERAGE
42
44
87
REFINANCING
LIQUIDITY
1
1
93
CONSOLIDATED RANK: SAFETY
1
1
93
21

Financial reporting date of Safety Rank:

Carl Zeiss Meditec stock analysis in respect ot important safety metrics. The higher the rank, the lower the leverage and the more cash is available to service the debt.

Stock analysis by the purely finance fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Carl Zeiss Meditec (AFX) from December 15, 2017.